Yen SH - Search Results

1

Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation.

Dayanandan R, Van Slegtenhorst M, Mack TG, Ko L, Yen SH, Leroy K, Brion JP, Anderton BH, Hutton M, Lovestone S. Dayanandan R, et al. Among authors: yen sh. FEBS Lett. 1999 Mar 12;446(2-3):228-32. doi: 10.1016/s0014-5793(99)00222-7. FEBS Lett. 1999. PMID: 10100846 Free article.

2

FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion.

Yen S, Easson C, Nacharaju P, Hutton M, Yen SH. Yen S, et al. Among authors: yen sh. FEBS Lett. 1999 Nov 12;461(1-2):91-5. doi: 10.1016/s0014-5793(99)01427-1. FEBS Lett. 1999. PMID: 10561502 Free article.

3

Pick's disease is associated with mutations in the tau gene.

Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, Cairns N, Lantos PL, Rossor M, Iwatsubo T, Davies Y, Allsop D, Furlong R, Owen F, Hardy J, Mann D, Hutton M. Pickering-Brown S, et al. Among authors: yen sh. Ann Neurol. 2000 Dec;48(6):859-67. Ann Neurol. 2000. PMID: 11117542

4

Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions.

DeTure M, Ko LW, Yen S, Nacharaju P, Easson C, Lewis J, van Slegtenhorst M, Hutton M, Yen SH. DeTure M, et al. Among authors: yen s, yen sh. Brain Res. 2000 Jan 17;853(1):5-14. doi: 10.1016/s0006-8993(99)02124-1. Brain Res. 2000. PMID: 10627302

5

Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.

Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M, Yen SH. Nacharaju P, et al. Among authors: yen s, yen sh. FEBS Lett. 1999 Mar 26;447(2-3):195-9. doi: 10.1016/s0014-5793(99)00294-x. FEBS Lett. 1999. PMID: 10214944 Free article.

6

Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17.

Yen SH, Hutton M, DeTure M, Ko LW, Nacharaju P. Yen SH, et al. Brain Pathol. 1999 Oct;9(4):695-705. doi: 10.1111/j.1750-3639.1999.tb00551.x. Brain Pathol. 1999. PMID: 10517508 Free PMC article. Review.

7

Analysis of tauopathies with transgenic mice.

Hutton M, Lewis J, Dickson D, Yen SH, McGowan E. Hutton M, et al. Among authors: yen sh. Trends Mol Med. 2001 Oct;7(10):467-70. doi: 10.1016/s1471-4914(01)02123-2. Trends Mol Med. 2001. PMID: 11597522 Review.

8

Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells.

Ko L, Odawara T, Yen SH. Ko L, et al. Among authors: yen sh. Brain Res. 1997 Jun 20;760(1-2):118-28. doi: 10.1016/s0006-8993(97)00292-8. Brain Res. 1997. PMID: 9237526

9

Characterization of in vitro glycation sites of tau.

Nacharaju P, Ko L, Yen SH. Nacharaju P, et al. Among authors: yen sh. J Neurochem. 1997 Oct;69(4):1709-19. doi: 10.1046/j.1471-4159.1997.69041709.x. J Neurochem. 1997. PMID: 9326300 Free article.

10

Cytosine beta-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy.

Ko LW, Kulathingal JG, Yen SH. Ko LW, et al. Among authors: yen sh. Neurochem Res. 2007 Apr-May;32(4-5):823-32. doi: 10.1007/s11064-006-9218-4. Epub 2006 Dec 6. Neurochem Res. 2007. PMID: 17151917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters